Liquidia Corporation announced Dr. Roger Jeffs has been appointed as Chief Executive Officer (CEO) effective January 3, 2022 and will continue as a director on the board. He succeeds Damian deGoa who will remain a director of the Company and will provide transition support through January 31, 2022. Dr. Jeffs is the Vice-Chairman and co-founder of Kryia Therapeutics, and currently serves on the Board of Axsome Therapeutics.

Dr. Jeffs previously served on the Board of Directors of Albireo Pharma (ALBO) from 2017-2021.